State of Wyoming’s ANI Pharmaceuticals ANIP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$85.5K Buy
+1,033
New +$82.9K 0.01% 1442
2025
Q3
– Sell
-768
Closed -$50.1K – 1831
2025
Q2
$50.1K Buy
+768
New +$50K 0.01% 1572
2022
Q3
– Sell
-721
Closed -$21K – 1522
2022
Q2
$21K Buy
721
+306
+74% +$8.83K 0.01% 1398
2022
Q1
$12K Buy
415
+60
+17% +$2.24K 0.01% 1581
2021
Q4
$16K Sell
355
-6
-2% -$258 0.01% 1559
2021
Q3
$12K Buy
361
+81
+29% +$2.52K 0.01% 1002
2021
Q2
$10K Buy
+280
New +$9.53K 0.01% 1012

Other funds holding ANIP

State of Wyoming's ANIP Position: Q2 2026 in Review

State of Wyoming opened a new position in ANI Pharmaceuticals (ANIP) in Q2 2026: 1,033 shares worth $85.5K. The stake represents 0.01% of the portfolio and ranks #1442 among its holdings. This is a return to the name: State of Wyoming previously reported a position in ANIP as recently as Q2 2025.

State of Wyoming first reported a position in ANIP in Q2 2021 and has held it in 7 quarters since. 307 funds tracked by Wall St. Rank hold ANIP as of Q2 2026.

  • State of Wyoming held 1,033 shares of ANI Pharmaceuticals worth $85.5K as of Q2 2026.
  • ANI Pharmaceuticals was a new State of Wyoming position in Q2 2026.
  • ANI Pharmaceuticals made up 0.01% of State of Wyoming's portfolio in Q2 2026, its #1442 holding.
  • State of Wyoming first reported a position in ANI Pharmaceuticals in Q2 2021 and has held it in 7 quarters since.
  • 307 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q2 2026.

Based on State of Wyoming's 13F filing for Q2 2026, filed 6 Aug 2026.